VTAK Catheter Precision, Inc.

$0.81 -13.33%

Healthcare · Surgical & Medical Instruments & Apparatus

Catheter Precision, Inc. (VTAK) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $2 million. Shares last traded at $0.81, 84.6% below their 52-week high. Over the past year the stock is up 83.1%. Net profit margin is -2098.0%, below the peer median of -7.6%. Revenue grew 95.0% year over year.

Market Cap

$2M

Shares Out

2.7M

EPS (TTM)

$-218.57

P/E Ratio

—

P/S Ratio

2.66

P/B Ratio

0.23

Dividend / Share

—

Dividend Yield

—

52-Week High

$5.27

52-Week Low

$0.15

Volume

833

Avg Vol (3m)

3,247.349

Performance

-22.82%

-0.07%

-37.90%

-69.99%

YTD

-58.23%

+83.14%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

37.72

SMA (50)

$0.94

SMA (200)

$1.76

Price vs SMA50

-13.83%

Price vs SMA200

-54.08%

ATR (14)

$0.07

Financials

Revenue

$1M

Net Income

$-17M

Gross Margin

92.3%

Operating Margin

-2581.6%

Net Margin

-2098.0%

Return on Equity

-179.6%

Return on Assets

-49.0%

Current Ratio

0.06

Debt / Equity

0.32

Revenue Growth (YoY)

+95.0%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
FY 2022	$-25.98	2023-03-28
Q3 2022	$-28.00	2022-11-14
Q2 2022	$-0.53	2022-08-16
FY 2022	$-248.22	2023-03-28
Q3 2022	$-186.48	2022-11-14
Q2 2022	$-3.56	2022-08-16

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

VTAK vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

2.66 / 2.52 med

+6% premium

Net margin vs peers

-2098.0% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.